Lonza acquires Simbiosys Biowares' preclinical cell and molecular biology group
Lonza has completed the acquisition of the preclinical cell and molecular biology assets of Simbiosys Biowares India, a biology outsourcing company, expanding its cell-biology platform.
Simbiosys’s cell and molecular biology group specialises in primary cell isolation and tissue sourcing and in performing preclinical services to mid-size pharmaceutical companies.
Simbiosys Biowares India offers preclinical services in the areas of: drug discovery services (includes lead validation and lead development using in-vitro and in-vivo ADME-Tox assays); molecular biology contract research services (including DNA amplification and cloning, DNA/RNA isolation, synthetic gene construction and quantitative PCR); biopharmaceutical services (includes process design optimisation of fermentation technology for producing small-molecules, proteins and mAbs for therapeutic, diagnostic and research applications).
Phone: 1300 657508
Mercodia Insulin MBeads Assay
The assay is designed to offer high accuracy by specifically measuring human insulin while...
Waters BD FACSDiscover A7 Cell Analyzer
The BD FACSDiscover A7 Cell Analyzer combines high spectral resolution and sensitivity with...
Lumiprobe CytoTracer fluorescent cell dyes
The dyes rapidly penetrate cells, form intracellular membrane-impermeable products, and deliver...
